Overview of the current promising approaches for the development of an ef- fective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding the immunopathogenesis of COVID-19. However, many clinical trials are underway across the world for screening effective drugs against...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12326
- Acceso en línea:
- https://doi.org/10.1016/j.intimp.2020.106928
http://hdl.handle.net/20.500.12010/12326
- Palabra clave:
- COVID-19
SARS-CoV-2
Immunopathogenesis
Vaccines
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido